Stroke I64
Conditions
Interventions
Group 1: This study consists of the following elicitation methods:
1) Qualitative semi-structured patient interviews and expert interviews (2020
N = 19).
2) Qualitative pretest interviews to test a survey instrument using the think-aloud method (2021
N = 18).
2) Discrete choice experiment using a quantitative survey via an online questionnaire (2022-2023
number of participants will be known after study completion)
Sponsors
Hochschule Neubrandenburg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. stroke patients (experimental group). Patients with a diagnosis of stroke. Preferably experience in rehabilitative therapy (neurorehabilitation) Residence in Germany Able to read and understand the German language Willing and able to provide online informed consent stating that they understand the purpose and procedures of the study and are willing to participate in the study 2. general population (control group) Resident in Germany Able to read and understand the German language Willing and able to provide online informed consent stating that they understand the purpose and procedures of the study and are willing to participate in the study
Exclusion criteria
Exclusion criteria: For both populations: Resident in Germany Not able to read and understand the German language Unwilling and unable to provide online informed consent stating that they understand the purpose and procedures of the study and are willing to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Our primary endpoint is to weight the criteria that impact patient acceptance when interacting with digital technologies for healthcare and as an adjunct to traditional care provided by a human professional. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end points include (1) a benefit-burden assessment, (2) an overall comparison of the relative importance of attributes, and (3) identification of key attributes that influence patient adherence. Our exploratory end points include (1) assessment of heterogeneity and (2) subgroup analysis. | — |
Countries
Germany
Contacts
Public ContactAxel Mühlbacher
Hochschule Neubrandenburg
Outcome results
None listed